Submissions

Login or Register to make a submission.

Author Guidelines

Guidelines for Authors

INSTRUCTIONS FOR AUTHORS

Aligned with the recommendations of the International Committee of Medical Journal Editors (ICMJE), the guidelines of the Committee on Publication Ethics (COPE), and the principles of Open Science.

1. Focus and Scope

The Cuban Journal of Biomedical Research (Rev Cubana Invest Bioméd) is the official scientific publication of the Cuban Society of Basic Biomedical Sciences. Its mission is to contribute to the development of the biomedical sciences—including physiological and morphological sciences, biochemistry, bioinformatics, and medical robotics—through the publication of articles of proven quality, novelty, and scientific relevance.

It is a continuously publishing journal, managed through the OJS (Open Journal Systems) platform at https://revibiomedica.sld.cu, with free, open access and no article processing charges or article page charges. All content is distributed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

The content is aimed primarily at health professionals and professionals in related sciences belonging to Cuba's National Health System and to those of other countries. The editorial committee will assess the scientific contribution of the submitted work regardless of the authors' national or foreign origin or institutional affiliation.

2. General Aspects of the Editorial Process

After registering on the site (www.revibiomedica.sld.cu), the author will submit their manuscript once they declare having met the mandatory requirements, accept the stipulated conditions, and correctly enter the metadata associated with authorship. From that point on, the author may track the status of their submission online, respond to comments received, and resubmit the corrected version.

Documents submitted by authors are considered confidential throughout the evaluation process. Their content will be disclosed to third parties only if a decision is made to publish them. Accordingly, reviewers and editors must refrain from disclosing any aspect of the work under consideration to anyone outside the editorial committee.

The journal adheres to the quality criterion related to editorial endogamy: editors, reviewers, and editorial committee members who are authors of a submission do not participate in the editorial process or in decisions regarding their own manuscript.

If an author decides not to continue with the publication process for their manuscript, they must notify the journal's editorial office in writing, in order to avoid an ethical conflict.

Once a manuscript is accepted, it undergoes a copyediting process that organizes the text according to the structure approved for publication, provides clarity and transparency, and reviews—in addition to grammar and spelling—the methodological elements, presentation of results, and discussion, as well as overall compliance with the sections expected of a scientific article. The submission then goes through quality control, design, and, where applicable, translation; once these steps are complete, the author receives the final version for approval, at which point only minor typographical and layout errors may be corrected.

The editorial committee reserves the right to make stylistic modifications and to shorten texts where necessary, while committing to respect the original content and consult with the authors, who must approve their agreement with the resulting document in writing. Authors are responsible for the opinions expressed in their work.

3. Ethical Principles and Good Publication Practices

The journal subscribes to the principles of scientific integrity set out by the International Committee of Medical Journal Editors (ICMJE) in its Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and applies the procedures and flowcharts of the Committee on Publication Ethics (COPE) in the event of any suspected scientific misconduct.

3.1 Authorship Criteria (ICMJE)

Only individuals who simultaneously meet the following four criteria are recognized as authors. Anyone who contributes significantly but does not meet all four criteria should be listed in the Acknowledgments section, not as an author (thereby avoiding honorary, courtesy, gift, or "ghost" authorship).

Criterion Description (ICMJE)
1 Substantial contributions to the conception or design of the work, or to the acquisition, analysis, or interpretation of the data.
2 Drafting the manuscript or critically revising it for important intellectual content.
3 Final approval of the version to be published.
4 Agreement to be accountable for all aspects of the work, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

In keeping with editorial policy, a list of each signing author's contributions must be included at the end of the text—after the References—regardless of the number of co-authors. Use of a CRediT-type taxonomy (Contributor Roles Taxonomy) is recommended to specify each person's role (for example: conceptualization, data curation, formal analysis, investigation, methodology, writing – original draft, writing – review and editing, etc.).

Example of an authorship contribution statement: Pedro González Pérez: conceptualization, statistical processing. María Rodríguez Morales: methodology, selection of the study sample. Alberto Pérez Gómez: investigation, development of the measurement instrument.

The editorial committee reserves the right to assess authorship effects according to the characteristics of the research, which will be communicated to the authors during the evaluation process.

3.2 Conflicts of Interest

All authors must declare any financial, institutional, personal, or other relationship that could be perceived as a conflict of interest in relation to the submitted work (funding, fees, patents, leadership positions, among others). The absence of conflicts must also be explicitly declared.

In accordance with the International Committee of Medical Journal Editors (ICMJE), the journal requires submission of the standardized ICMJE Conflict of Interest Disclosure Form, available at https://www.icmje.org/disclosure-of-interest/translations/spanish-2022.pdf, which requires authors to specifically declare financial relationships (fees, grants, patents) and non-financial relationships from the past 36 months. This declaration must be submitted as part of the manuscript and will appear in the published version.

3.3 Informed Consent, Ethical Approval, and Study Registration

  • Research involving human subjects: must have been conducted in accordance with the principles of the Declaration of Helsinki. Approval by a Research Ethics Committee (or institutional Ethics Committee) and the informed consent of participants must be declared; in case reports, the informed consent of the patient (or legal guardian) for publication, including images, must be documented.
  • Research involving animals: must comply with institutional and national regulations on the care and use of laboratory animals, and approval by the corresponding committee must be declared.
  • Clinical trials: prior registration in a WHO-recognized platform is recommended (for example, the Cuban Public Registry of Clinical Trials, RPCEC), with the registration number declared.
  • Personal data protection: patients' names, initials, or medical record numbers must not appear in the text, tables, or figures, unless the information is essential and explicit consent has been obtained.

3.4 Scientific Integrity, Previously Unpublished Manuscripts, and Preprints

Manuscripts constituting redundant or duplicate publication, undue fragmentation of results ("salami slicing"), plagiarism (including self-plagiarism), or data fabrication or falsification will not be accepted. All manuscripts may be subject to text-similarity screening. Detection of these practices at any stage of the editorial process—or after publication—will result in rejection, correction, or retraction, in accordance with COPE flowcharts.

If the manuscript is not "previously unpublished," authors are obliged to state when and where it has been made public. The journal accepts manuscripts from preprint servers that comply with the standards established for scientific articles (SciELO Preprints, medRxiv, Preprints.org, and other reputable services). The article must not contain text fragments from work previously published or under review in other journals or media without proper citation.

3.5 Corrections, Expressions of Concern, and Retractions

For errors detected after publication that affect the interpretation of the data or the scientific validity of the work, the journal will issue a corrigendum. In confirmed cases of scientific misconduct, the article will be formally retracted and will remain visible with the corresponding notice, in accordance with COPE guidelines.

3.6 Use of Generative Artificial Intelligence

Consistent with Open Science principles, the journal requires full transparency regarding the use of artificial intelligence (AI) tools, including large language models (LLMs) and other generative AI technologies, at any stage of a manuscript's conception, preparation, or revision. Authors are solely responsible for the integrity, accuracy, and originality of the published content, including any parts produced with AI assistance. AI may act as a support tool but can never be listed as an author or assume responsibility for the work, since it cannot be held accountable for its content.

Authors must explicitly declare any use of AI tools in preparing the manuscript. The declaration must include:

Element Description
Tool name and version E.g., ChatGPT-4o, Claude Sonnet 4.5, Gemini 2.5 Pro
Date of use Month and year the tool was used
Specific purpose Writing, language editing, image generation, data analysis, translation, etc.
Sections affected Which parts of the manuscript were involved?
Author verification Confirmation that the authors reviewed, validated, and take full responsibility for the content

Where the declaration is placed depends on its purpose: if AI was used for writing, editing, or translation, it is declared in the Acknowledgments section; if used for methodology, data collection, or analysis, it is declared in the Methods section; if used to generate or edit images, figures, or visual elements, it is declared in the caption of the corresponding figure.

Permitted and prohibited uses of AI:

Use Status Conditions
Language, grammar, and spelling editing Permitted No declaration required for basic assistance (e.g., standard spell-checkers)
Translation of manuscript sections Permitted with declaration Must be declared in Acknowledgments
Substantial text generation or restructuring Permitted with declaration Must be declared in Acknowledgments; authors must verify accuracy
Generation of images, figures, or graphic elements Permitted with declaration Must be declared in the figure caption; photographic or factual-evidence images may not be generated or altered by AI
Data analysis or code development Permitted with declaration Must be declared in Methods; authors must verify reproducibility
Formation of ideas or hypotheses Restricted Considered a core intellectual contribution requiring human originality
Generation of original research data Prohibited AI may not create, alter, or manipulate original research data, laboratory images, radiographs, or measurements
Peer review Prohibited for reviewers Reviewers must not upload manuscripts to public AI platforms; doing so constitutes a breach of confidentiality

Authors are fully responsible for verifying the accuracy of all AI-generated content—including bibliographic references, since AI can generate nonexistent references or "hallucinations"—for ensuring that content does not infringe copyright, for preventing AI from introducing bias or misinformation, and for confirming that the manuscript reflects the judgment and intellectual control of the human authors.

Authors must not enter non-anonymized data on human participants, unpublished third-party manuscripts, confidential information or information subject to intellectual property agreements, or images of identifiable individuals into public AI tools without the corresponding ethical safeguards. Reviewers, in turn, must not upload manuscripts under evaluation to public AI platforms, as this constitutes a breach of the confidentiality of the peer-review process.

Undisclosed use of AI tools, generation of substantial content without adequate human oversight, or presentation of AI-generated content as original human work are considered unethical conduct under COPE guidelines. The journal reserves the right to reject the manuscript at any stage of the editorial process, request revisions or corrections, withdraw the article after publication, or notify the authors' affiliated institutions, if necessary.

3.7 Data Availability Statement

Consistent with the Open Science principles underlying the journal's editorial policy, every manuscript must include, at the end of the article—after the references—a section titled "Data Availability," clearly and verifiably specifying how the data used, analyzed, or generated during the research can be accessed.

Authors must indicate one of the following options:

  1. Data publicly available in a repository: provide the repository name, the persistent identifier (DOI, accession number, or other stable identifier), and the access conditions.
  2. Data available upon request: specify the request procedure, the person responsible for managing access, and the estimated response time.
  3. Data restricted for ethical, legal, or confidentiality reasons: justify the restriction, indicate the embargo period if applicable, and describe the controlled-access mechanisms or sample data that can be shared.
  4. Data included as supplementary material: indicate the format, file structure, and instructions necessary for reuse.
  5. No new data were generated or analyzed: valid only for review articles, meta-analyses using already published data, or purely theoretical methodologies, and must be duly justified.

When data are deposited in a repository, the repository must assign persistent identifiers, guarantee long-term accessibility, and preferably hold certification (e.g., CoreTrustSeal) or be indexed in recognized registries (re3data, FAIRsharing). Personal repositories, institutional sites without preservation guarantees, and general-purpose cloud storage platforms will not be considered adequate.

By submitting their manuscript, authors guarantee that the declared data faithfully correspond to those used in the presented analysis, that they will maintain accessibility for a minimum of five years after publication, and that they will notify the editorial office of any change in availability. The journal reserves the right to request verification of data accessibility prior to acceptance, to reject manuscripts whose statement is incomplete or ambiguous, and to publish corrections or retractions in response to inaccuracies detected after publication.

Exceptions to these requirements must be requested in writing from the responsible editor at the time of submission, who will assess their justification according to applicable ethical and legal criteria.

4. Editorial Process

Manuscripts are submitted exclusively through the journal's online Editorial Management System (OJS): https://revibiomedica.sld.cu. At least one of the authors must be registered on the platform.

  1. Reception and preliminary review (desk review): within ten (10) business days of entry into the system, the editorial committee decides whether to ACCEPT or REJECT the manuscript for processing. Exceptionally, and depending on the complexity of the topic, this period may be extended by up to twenty (20) additional days for expert consultations.
  2. Peer review: manuscripts accepted in the preliminary review undergo evaluation by specialists external to the editorial committee, under a peer-review model that preserves the impartiality of the process. Reviewers' role is advisory and non-binding: their assessments are forwarded to the editor, who makes the final decision on whether to publish the document.
  3. Post-acceptance editorial process: once a manuscript is ACCEPTED, ninety (90) days are allotted to complete the editorial process (copyediting, quality control, design, and translation, as described in Section 2), which may be suspended if authors fail to respond to reviewers' comments. Unjustified delays may lead to rejection, mainly due to the loss of currency, relevance, or timeliness of the references.
  4. Communication of the decision: any rejection is communicated to the authors with reasons.

The articles and opinions published are the sole responsibility of their authors and do not necessarily reflect the position of the publishing institution or its editorial committee.

5. Article Types and Their Characteristics

The journal publishes the following types of contributions. Any manuscript that does not meet the described conditions will be rejected immediately during the preliminary review.

Article type Maximum length Authors (max.) References Abstract/body structure
Editorial ≤ 1,000 words Commissioned by the editorial committee, or signed by its author(s) ≤ 5 Free format, no structured abstract
Original article 4,500 words (including references) No fixed limit* ≥ 50% from the last 5 years IMRaD: Introduction–Objectives–Methods–Results–Conclusions (250 words)
Brief communication 10,000 characters (7–9 pages) No fixed limit* Up to 10 Abstract (250 words)–Introduction–Methods–Results–Discussion–Conclusions
Review article 5,000 words (excluding references) 3 ≥ 70% from the last 5 years Introduction–Objective(s)–Methods (search strategy)–Development–Conclusions
Case report 3,500 words 3 10–15 Abstract–Introduction–Case Presentation–Discussion–References
Letter to the editor 1,500 words (guideline) No fixed limit* Relevant bibliographic support Free text with rationale; reference to the article/topic commented on
Bioengineering Depending on the nature of the work (applies original/review criteria) No fixed limit* ≥ 50% from the last 5 years IMRaD adapted to the design, validation, or application of biomedical devices/algorithms

* No fixed numerical cap is set, but the editorial committee will assess the appropriateness of the number of authors in relation to the scope and complexity of the work, in accordance with ICMJE authorship criteria.

5.1 Editorial

Expresses positions and views directly related to a topic of interest to the journal or to a specific scientific situation. It may be commissioned by the editorial committee from a particular individual, or result from a collective reflection signed by the editorial committee. Maximum length: 1,000 words. Up to 5 references. No structured abstract required.

5.2 Original Articles

Report results of previously unpublished research. Maximum length: 4,500 words, including references. IMRaD structure:

  • Title: in Spanish and English; concise, informative, without acronyms or abbreviations; maximum 15 words.
  • Structured abstract (max. 250 words, in the past tense, in Spanish and English): Introduction–Objectives–Methods–Results–Conclusions.
  • Keywords: 3 to 10, in order of importance and separated by semicolons; at least one is recommended to also appear in the title. Preferably based on the DeCS thesaurus (Health Sciences Descriptors).
  • Introduction: brief, relevant background, rationale for the scientific problem, objective(s) of the work.
  • Methods: type of study, period and location; population and sample; inclusion, exclusion, and elimination criteria; variables; data collection and analysis procedures; appropriate and reproducible statistical method; declared ethical aspects.
  • Results: consistent with the objectives; a maximum of 5 elements among tables, figures, and graphs, without duplicating information.
  • Discussion: critical analysis in relation to national and international literature; scope and limitations; applicability and generalizability.
  • Conclusions: in the final paragraph of the discussion (not as a separate section), consistent with the objectives and results.
  • References: at least 50% published in the last five years. Citations in superscript, in parentheses, after the punctuation mark.

5.3 Brief Communications

Technically innovative, unique, and highly current work that does not develop the background of the problem in detail. Maximum length: 10,000 characters (7–9 pages, Arial 12, single spacing). Structure: title with authors, institutions, and corresponding author; abstract (250 words); keywords (6); Materials and Methods; Results; Discussion; Conclusions; up to 10 references, 2 tables, and 2 figures.

5.4 Review Articles

Maximum length: 5,000 words, not counting references; up to 3 authors. Structure: title (Spanish/English, ≤ 15 words); structured abstract (Introduction–Objective(s)–Methods–Conclusions, ≤ 250 words, Spanish/English); keywords (≥ 3, DeCS); Introduction with bibliographic rationale for the topic; Methods with source-selection criteria, search engines used, and review period; Development with critical interpretation, comparison of agreements and differences among studies, and identification of limitations or contributions; clear and relevant Conclusions; references with at least 70% from the last five years. Maximum of 4 tables and 4 figures.

Authors of systematic reviews and meta-analyses are encouraged to follow the PRISMA guideline, available through the EQUATOR Network (Enhancing the Quality and Transparency of Health Research).

5.5 Case Reports

Describe one or more clinical cases of exceptional observation, or a novel aspect of an already known disease or syndrome, with a contribution of current interest to knowledge of the topic. Before writing the report, authors are advised to verify the publication's value against the international literature. Brevity is its essential feature. Maximum length: 3,500 words; up to 3 authors; 10 to 15 up-to-date references with their corresponding URLs. Structure: Abstract–Introduction–Case Presentation–Discussion–References.

Use of the CARE (CAse REport) guideline from the EQUATOR Network is recommended for writing case reports.

5.6 Letters to the Editor

Documents expressing the authors' ideas, positions, or disagreements regarding content published in the journal or topics within the specialty, subject to prior evaluation by the editorial committee. They must comply with the ethical principles of scientific publication and support their arguments with corresponding bibliographic references, in accordance with the journal's standards.

5.7 Bioengineering

Section devoted to work in bioinformatics, medical robotics, and applied biomedical engineering; depending on the nature of the study (empirical, technological design/validation, or review), the structural and length criteria corresponding to an original or review article apply.

6. General Manuscript Preparation

6.1 Institutional Affiliation, ORCID, and Title Page Format

It is mandatory to provide each author's complete and current institutional affiliation, as well as their ORCID number (https://orcid.org). Authors will be listed according to their contribution, each on a separate line and identified with consecutive Arabic numerals in superscript.

The affiliation format to be followed is: Institution (including faculty and department, if applicable, separated by commas), city, country; positions or academic/scientific degrees are not required.

Example: Universidad de Ciencias Médicas de La Habana, Facultad de Ciencias Básicas Biomédicas, La Habana, Cuba.

The corresponding author and their email address must be identified. Registration in other author identifiers (e.g., Google Scholar, Scopus Author ID) is also recommended where available.

6.2 Abstracts and Keywords

Abstracts will be presented in Spanish and English, with the structure corresponding to the article type (see Section 5). They must not include information not addressed in the article, nor use acronyms or abbreviations. Keywords will be placed at the foot of the abstract, in order of importance and separated by semicolons; use of the DeCS thesaurus (Health Sciences Descriptors, https://decs.bvs.br) is recommended, and, for English, MeSH (Medical Subject Headings, https://www.ncbi.nlm.nih.gov/mesh).

6.3 Tables and Figures

Each table's title must correspond appropriately to its content; the information presented must justify its inclusion and must not repeat what has already been stated in the text. Column headers will have no empty cells. Tables must be self-explanatory and presented in tabulated format, not as an image.

Only necessary and relevant figures will be included, with captions corresponding to their content, numbered consecutively with Arabic numerals according to their first mention in the text. Graphs and diagrams must be submitted in an editable format for the editorial team (image formats such as JPG or GIF should be avoided for graphs). Photographs in JPG format must have a minimum resolution of 300 dpi.

If an image from another publication is used, the author must request the corresponding permissions from the rights holder and cite the source. For images generated using AI tools, their use must be explicitly declared in the caption of the corresponding figure, in accordance with Section 3.6; such images are recommended for illustrative purposes only, never as primary scientific evidence (for example, clinical images or microscopy results).

6.4 Abbreviations, Acronyms, and Symbols

Their use should not be excessive. They must be preceded by the full name or meaning the first time they appear in the text. They should not appear in titles or abstracts. Internationally used abbreviations should be employed.

6.5 International System of Units and Numerical Format

All clinical laboratory results will be reported in International System of Units (SI) or units permitted under this system. If traditional units are also desired, they should be written in parentheses.

Example: blood glucose: 5.55 mmol/L (100 mg/100 mL).

Decimals will be expressed with a comma, not a period [as per Spanish-language convention in the original journal]. The percent symbol will be written with a space between the number and the symbol (e.g., 10 %).

6.6 References

For their preparation, authors are directed to consult the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (Vancouver style, ICMJE), available at https://bvs.sld.cu/revistas/recursos/vancouver_2012.pdf. References should be as necessary and well-focused, cited in superscript after the punctuation mark and in parentheses, seeking an appropriate balance between relevant national and international literature on the topic.

Multiple, consecutive citations will be written separated by commas (for example, references 1 through 5 are cited as 1,2,3,4,5). No element will be highlighted with capital letters or underlining, except URLs. Up to the first 6 authors of each reference will be listed, followed by "et al." where applicable. Journal titles will be abbreviated according to Index Medicus (List of Journals Indexed in Index Medicus).

Any reference with a source (scientific journals, websites, books, or other resources) from 2015 onward must be accompanied by its electronic location (DOI or URL); DOIs do not require an access date. References to articles approved for publication but not yet published will be included, indicating the journal title and the clarification "forthcoming" in parentheses. Mention of personal communications and unpublished documents should be avoided as far as possible; they will only be mentioned in the text in parentheses if essential.

6.7 Models and Appendices

These will be presented at the end of the article, after the references, in vertical format, numbered consecutively with Arabic numerals, and mentioned in the text.

6.8 Writing Quality

Every manuscript must be submitted with adequate writing quality and spelling in Spanish, and must comply with the ethical principles of research described in Section 3. Work that does not meet these conditions will be rejected immediately.

7. Manuscript Submission

Manuscripts are submitted exclusively through the journal's online Editorial Management System (OJS): www.revibiomedica.sld.cu, following a five-step process: registration/login, entry of metadata (authors, affiliation, ORCID, title, structured abstract, and keywords), file upload, verification, and confirmation of submission.

8. Copyright and Publication License

Authors who publish in this journal agree to the following terms:

  1. Authors retain their copyright and grant the journal the right of first publication of their work, which is simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which allows third parties to share the work provided its authorship and its first publication in this journal are acknowledged.
  2. Authors may enter into other separate, non-exclusive licensing agreements for the distribution of the published version of the work (for example, depositing it in an institutional repository or including it in a monographic volume), provided that its initial publication in this journal is acknowledged.
  3. Authors are permitted and encouraged to disseminate their work online (for example, in institutional repositories or on their own website) before and during the submission process, which can lead to productive exchanges and increase citations of the published work. In such cases, this should be explicitly declared during the submission process.

9. Privacy Statement

The names and email addresses registered on the platform will be used exclusively for the stated editorial purposes and will not be shared with third parties or used for other purposes.

ARTÍCULOS ORIGINALES

Su extensión no superará las 4 500 palabras, incluidas las referencias bibliográficas.

Al final del texto, y después de las Referencias Bibliográficas, deberá constar un listado de contribución de autoría, independientemente del número de contribuyentes. El comité editorial de la revista se reserva el derecho de considerar, según las características de la investigación, los efectos de autoría, lo que será comunicado a los autores durante el proceso de evaluación.

 

Ejemplo:

Pedro González Pérez: realizó procesamiento estadístico.

María Rodríguez Morales: seleccionó la muestra del estudio.

Alberto Pérez Gómez: elaboró el instrumento de medición.

 

Título

Debe corresponder con el tema del artículo. Ser conciso, comprensible e informativo. No debe exceder de 15 palabras. En español e inglés. No debe incluir siglas ni abreviaturas. Si se utilizan nombres de instituciones, deben ser los oficiales y estar actualizados.

Resumen

Estructurado por secciones. En este caso debe seguir la siguiente estructura: Introducción-Objetivos-Métodos-Resultados-Conclusiones.

Tiene un límite máximo de 250 palabras. Ofrece una adecuada idea de lo que trata el trabajo. Se escribe en pasado. Debe enviarse en español e inglés (abstract).

Palabras clave

Deben ser concretas y representativas del contenido semántico del documento, tanto en los contenidos principales como secundarios. Debe haber como mínimo 3 palabras o frases clave. Se recomienda utilizar el tesauro DeCs. (Descriptores en Ciencias de la Salud) http://decs.bvs.br/E/homepagee.htm

Introducción

Presentar antecedentes breves, claros y apropiados. Fundamentación del problema científico. Describir con claridad el objetivo(s) del trabajo.

Métodos

Definir el tipo de investigación o estudio, período y lugar. Definir la población o grupo de estudio, así como los criterios de inclusión, exclusión y eliminación. Describir los criterios y la justificación para la selección de la muestra si se requiere.

Las variables analizadas deben ser descritas con claridad. Exponer con claridad los métodos de recolección de la información y de procesamiento y análisis que se utilizaron. El método estadístico debe el apropiado según el tipo de estudio. Debe cumplir con el principio de poder ser reproducido por otros investigadores. Declarar los aspectos éticos particulares para el estudio.

Resultados

Exposición acorde con los objetivos del trabajo. Uso apropiado de los estadígrafos (cuando se requieran). Figuras y tablas destacan los resultados relevantes sin incurrir en repeticiones de información entre unas y otras. Se permiten un máximo de 5 entre tablas, figuras o gráficos estadísticos.

Discusión

Realizar análisis crítico de los resultados del estudio a la luz de los trabajos publicados por otros investigadores del área nacional e internacional. Explicar el alcance y las limitaciones de los resultados alcanzados. Describir la posible aplicabilidad y generalización de los resultados.

Conclusiones

Deben poseer un adecuado grado de generalización. Responden a los objetivos del estudio y están en correspondencia con los resultados y la discusión. No repetir resultados. Se escribirán en forma de párrafo al final de la discusión no como un tópico aparte.

 

Referencias Bibliográficas

Deben ser la necesarias y bien acotadas (con superíndice, después del signo de puntuación y entre paréntesis). Debe contener el 50 % de trabajos publicados en los últimos cinco años.

Estar representada la literatura nacional e internacional relevante sobre el tema.

 

Tablas

El título de la tabla se debe corresponder adecuadamente con su contenido. La información que presentan debe justificar su existencia. No repetir información ya señalada en el texto.  Se aceptarán hasta cuatro tablas como máximo.

Figuras

Solo se presentarán las que sean necesarias y pertinentes. Los pies de figuras se deben corresponder adecuadamente con estas. Un máximo de 3. No serán superiores a 1 Mb cada una.

Gráficos y esquemas

Deben ser editables, es decir, el editor debe poder trabajar dentro de ellos sin necesidad de tener que rehacerlos si precisa de cambios. No serán superiores a 500 Kb cada uno.

 

Otros Aspectos

La presentación de su propuesta de publicación debe tener una calidad adecuada en cuanto a la redacción y ortografía, y cumplir con los principios éticos de la investigación.

 

Los artículos que no cumplan con estas condiciones serán rechazados de inmediato.

SHORT COMMUNICATIONS

 

The text is similar than an original paper but the extension is limited to 10 000 characters and it could include two tables and two figures maximum and 10 references.

This short communication should be divided in Title with authors, institutions and corresponding author, Abstract (250 words), Key words (6), Materials and Methods, Results, Discussion, Conclusions and References.

Short communications are concise articles that are no longer than 10 000 words (7-8 pages) in Arial 12 simple space. Short communications do not cover in detail background information about the problems treated or the applications, rather they provide key pointers to the reader. The work reported needs to be technically sound, innovative and significantly unique, advancing the state of the art.

ARTÍCULOS DE REVISIÓN

Su extensión no sobrepasará las 5 000 palabras, sin incluir las referencias bibliográficas.

No superará los 3 autores.

Título

Debe corresponder directamente con el tema del artículo. Ser conciso, comprensible e informativo. No debe exceder de 15 palabras. En español e inglés. No debe incluir siglas ni abreviaturas.

 

Resumen

 Estructurado por secciones, en este caso debe cumplir la siguiente estructura: Introducción-Objetivo(s)- Métodos-Conclusiones.

Ofrece una adecuada idea de lo que trata el trabajo. Tiene un límite máximo de 250 palabras. En Español e Inglés.

Palabras Clave

Deben ser concretas y representativas del contenido semántico del documento, tanto en los contenidos principales como secundarios. Como mínimo 3 palabras o frases clave. Se recomienda utilizar el tesauro DeCs. (Descriptores en Ciencias de la Salud) http://decs.bvs.br/E/homepagee.htm

Introducción

Presentar antecedentes breves, claros y apropiados con su fundamentación bibliográfica. Debe ser un tema de importancia y pertinencia para la ciencia. Fundamentar el problema científico que origina la revisión. Describir con claridad los objetivos del trabajo.

Métodos

Criterio y justificación de la selección de las fuentes consultadas. Motores de búsqueda utilizados. Período que se toma para la revisión.

Desarrollo

Exposición acorde con los objetivos del trabajo. Figuras y tablas que destaquen los aspectos relevantes sin incurrir en repeticiones de información. Las figuras y tablas no excederán de cuatro de cada una de estas.Interpretación de los resultados señalados en la literatura consultada. Contrastar las diferencias y coincidencias de los estudios analizados. Realizar crítica de los resultados del estudio a la luz de los trabajos publicados por otros investigadores. Describir la posible aplicabilidad y generalización de los resultados. Incluir nuevos aspectos a considerar (en caso de ser necesario). Señalar o destacar las limitaciones o aportes de la revisión.

Conclusiones

Responden a los objetivos del estudio. Exponer conclusiones claras, concretas y pertinentes.

Referencias Bibliográficas

Deben ser la necesarias y bien acotadas (con superíndice, después del signo de puntuación y entre paréntesis). Debe contener el 70 % de trabajos publicados en los últimos cinco años.

Estar representada la literatura nacional e internacional relevante sobre el tema.

Otros Aspectos

La presentación de su propuesta de publicación debe tener una calidad adecuada en cuanto a la redacción y ortografía, y cumplir con los principios éticos de la investigación.

 

Los artículos que no cumplan con estas condiciones serán rechazados de inmediato.

REPORTES DE CASOS

Son artículos que describen uno o varios casos clínicos de excepcional observación, o novedoso aspecto de una enfermedad o síndrome previamente conocido, que representa un aporte de especial interés para el conocimiento del tema o el proceso descrito en la actualidad mundial. Antes de escribir un informe o presentación de caso se debe comprobar en la literatura internacional si tiene valor como publicación. La brevedad será la característica fundamental de este tipo de artículo. Su estructura incluye Resumen-Introducción-Presentación del caso- Discusión y Referencias bibliográficas.

La extensión máxima del texto será de hasta 3 500 palabras y se citarán entre 10 y 15 referencias bibliográficas con sus correspondientes URL y de actualidad (ver artículo original). Incluirán hasta 3 autores

CARTAS AL DIRECTOR

Se recibirán documentos que expresen las ideas, posturas o desacuerdos de los autores en relación con algunos de los contenidos publicados en la revista o temas propios de la especialidad previa evaluación por parte del comité editorial. Las cartas que cumplan con los principios éticos de la publicación científica serán publicadas. Los fundamentos planteados deben tener su correspondiente apoyo bibliográfico según las normas adoptadas por la revista.

Copyright Notice

Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes: Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons (CC-BY-NC 4.0) que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista. Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista. Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).

Como Revista Cubana de Investigaciones Biomédicas forma parte de la red SciELO, una vez los artículos sean aceptados para entrar al proceso editorial (revisión), estos pueden ser depositados por parte de los autores, si estan de acuerdo, en SciELO preprints, siendo actualizados por los autores al concluir el proceso de revisión y las pruebas de maquetación.

Privacy Statement

Los nombres y las direcciones de correo electrónico introducidos en esta revista se usarán exclusivamente para los fines establecidos en ella y no se proporcionarán a terceros o para su uso con otros fines.